Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The treatment was not recommended due to limited effectiveness and significant side effects.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

LLLT increases hair density and growth in AGA patients.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

AMT may be more effective than finasteride for hair growth in androgenetic alopecia.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Alitretinoin may help treat mild to moderate alopecia areata.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

AT-Grow, a natural product, might help with a common type of hair loss by reducing DHT levels.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Alefacept does not effectively treat severe alopecia areata.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Botulinum toxin type A injections are not effective for severe alopecia areata.

Tofacitinib may help treat severe hair loss, but more research is needed.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Asynchronous telemedicine for acne treatment is effective and improves access and productivity.

Accurate diagnosis of hair loss types is crucial for effective treatment.

Regenera Activa AMT effectively improves hair growth and reduces hair loss in androgenetic alopecia.

ITK inhibitors may effectively treat alopecia areata.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

CT60 polymorphism might increase the risk of Alopecia Areata.

Histopathological confirmation is crucial to accurately diagnose alopecia triangular temporal and avoid unnecessary treatments.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.